Skip to Content

WPI 1119 (Mirtazapine 45 mg)

Pill with imprint WPI 1119 is White, Elliptical / Oval and has been identified as Mirtazapine 45 mg. It is supplied by Watson Pharmaceuticals.

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1119

Mirtazapine 45 mg WPI 1119
Mirtazapine 45 mg WPI 1119
Mirtazapine 45 mg WPI 1119

Mirtazapine

Imprint
WPI 1119
Strength
45 mg
Color
White
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Tetracyclic antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-1119 Watson Pharmaceuticals, Inc.
63874-1155 Altura Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.